Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Bone Loss
  • Chronic Periodontitis
  • Intrabony Periodontal Defect
Type
Interventional
Phase
Phase 4
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: 45 sites with vertical intrabony alveolar defects will be selected. These defect sites will be allocated randomly into 3 groups as Group I, Group II and Group III. Group I will be treated with open flap debridement and filled with A-PRF Group II will be treated with open flap debridement and filled with Bioactive glass (Perioglas®) Group III will be treated with open flap debridement and filled Bioactive glass (Perioglas®) and A-PRF. Masking: Double (Participant, Outcomes Assessor)Masking Description: patient and statistician will be masked about the treatment regimenPrimary Purpose: Treatment

Participation Requirements

Age
Between 25 years and 55 years
Gender
Both males and females

Description

45 sites with vertical intrabony alveolar defects will be selected. These defect sites will be allocated randomly into 3 groups as Group I, Group II and Group III. Group I will be treated with open flap debridement and filled with A-PRF Group II will be treated with open flap debridement and filled ...

45 sites with vertical intrabony alveolar defects will be selected. These defect sites will be allocated randomly into 3 groups as Group I, Group II and Group III. Group I will be treated with open flap debridement and filled with A-PRF Group II will be treated with open flap debridement and filled with Bioactive glass (Perioglas®) Group III will be treated with open flap debridement and filled Bioactive glass (Perioglas®) and A-PRF.

Tracking Information

NCT #
NCT04767243
Collaborators
Not Provided
Investigators
Principal Investigator: surinder sachdeva, M.D.S. PROFESSOR
About Us
Innovation
Privacy
Terms
Copyright
Get Well Soon © Copyright 2024